Endothelial cell vehicles for delivery of cytotoxic genes as a gene therapy approach for carcinoma of the ovary

Clinical Cancer Research

Volumn 4, Issue 2, 1998, Pages 265-270

  Rancourt, Claudine ^a   Robertson III, Matthew W ^b   Wang, Minghui ^a   Goldman, Corey K ^a   Kelly, Joseph F ^b   Alvarez, Ronald D ^b   Siegal, Gene P ^b   Curiel, David T ^a,b  

^a Department of Pharmacology and Toxicology and Mass Spectrometry Core Facility   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CANCER SURVIVAL; CANCER THERAPY; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; GENE THERAPY; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL; REPORTER GENE; SUBCUTANEOUS DRUG ADMINISTRATION; UMBILICAL VEIN;

ANIMALS; ENDOTHELIUM, VASCULAR; FEMALE; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; HUMANS; MICE; MICE, SCID; OVARIAN NEOPLASMS; SIMPLEXVIRUS; THYMIDINE KINASE; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0031938658     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Moolten, F. L. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res., 46: 5276-5281, 1986.
2. Hirschowitz, E., Ohwada, A., Pasca, W., Russi, T., and Crystal, R. In vivo adenovirus-mediated gene transfer of the Escherichia coli cytosine deaminase gene to human colon carcinoma-derived tumors induces chemosensitivity to 5-fluorocytosine. Hum. Gene Ther., 6: 1055-1063, 1995.
3. Sorscher, E. J., Peng, S., Bebok, Z., Allan, P. W., Bennett, J., Lee, L., and Parker, W. B. Tumor cell bystander killing in colonic carcinoma utilizing the Escherichia coli DeoD gene to generate toxic purines. Gene Ther., 1: 233-238, 1994.
4. Roth, J. A., and Cristiano, R. J. Gene therapy for cancer: what have we done and where are we going? J. Natl. Cancer Inst., 89: 21-39, 1997.
5. Yang, L., Hwang, R., Pandit, L., Gordon, E. M., Anderson, W. F., and Parekh, D. Gene therapy of metastatic pancreas cancer with intraperitoneal injections of concentrated retroviral herpes simplex thymidine kinase vector supernatant and ganciclovir. Ann. Surg., 224: 405-417, 1996.
6. Chen, S. H., Shine, H. D., Goodman, J. C., Grossman, R. G., and Woo, S. L. Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc. Natl. Acad. Sci. USA, 91: 3054-3057, 1994.
7. Hwang, H. C., Smythe, W. R., Elshami, A. A., Kucharczuk, J. C., Amin, K. M., Williams, J. P., Litzky, L. A., Kaiser, L. R., and Albelda, S. M. Gene therapy using adenovirus carrying the herpes simplex-thymidine kinase gene to treat in vivo models of human malignant mesothelioma and lung cancer. Am. J. Respir. Cell Mol. Biol., 13: 7-16, 1995.
8. Chen, L., Chen, D., Manome, Y., Dong, Y., Fine, H. A., and Kufe, D. W. Breast cancer selective gene expression and therapy mediated by recombinant adenoviruses containing the DF3/MUC1 promoter. J. Clin. Invest., 96: 2775-2782, 1995.
9. Rosenfeld, M. E., Wang, M., Siegal, G. P., Alvarez, R. D., Mikheeva, G., Krasnykh, V., and Curiel, D. T. Adenoviral-mediated delivery of herpes simplex virus thymidine kinase results in tumor reduction and prolonged survival in a SCID mouse model of human ovarian carcinoma. J. Mol. Med., 74: 455-462, 1996.
10. Sterman, D. H., Treat, J., Elshami, A. A., Amin, K., Molnar-Kimber, K., Coonrod, L. E., Recio, A., Wilson, J. M., Roberts, J. R., Litzky, L. A., Albelda, S. M., and Kaiser, L. R. A Phase I clinical trial of adenoviral-mediated herpes simplex virus thymidine kinase gene therapy for malignant mesothelioma: preliminary results. In: Gene Therapy of Cancer V, p. S29. San Diego, CA: 1996.
11. Yang, Y., Nunes, F. A., Berencsi, K., Furth, E. E., Gonczol, E., and Wilson, J. M. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA, 91: 4407-4411, 1994.
12. Yang, Y., Li, Q., Ertl, H. C., and Wilson, J. M. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol., 69: 2004-2015, 1995.
13. Goodman, J. C., Trask, T. W., Chen, S-H., Woo, S. L. C., Grossman, R. G., Carey, K. D., Hubbard, G. B., Carrier, D. A., Rajagopalan, S., Aguilar-Cordova, E., and Shine, H. D. Adenoviral-mediated thymidine kinase gene transfer into the primate brain followed by systemic ganciclovir: pathologic, radiologie, and molecular studies. Hum. Gene Ther., 7: 1241-1250, 1996.
14. Yee, D., McGuire, S. E., Brunner, N., Kozelsky, T. W., Allred, D. C., Chen, S-H., and Woo, S. L. C. Adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase in an ascites model of human breast cancer. Hum. Gene Ther., 7: 1251-1257, 1996.
15. Brand, K., Arnold, W., Bartels, T., Lieber, A., Kay, M. A., Strauss, M., and Dorken, B. Liver-associated toxicity of the HSV-tk/GCV approach and adenoviral vectors. Cancer Gene Ther. 4: 9-16, 1997.
16. Booyse, F. M., Quarfoot, A. J., Chediak, J., Sternerman, M. B., and Maciag, T. Characterization and properties of cultured human von Willebrand umbilical vein endothelial cells. Blood, 58: 788-796, 1981.
17. Rosenfeld, M. E., Feng, M., Michael, S. I., Siegal, G. P., Alvarez, R. D., and Curiel, D. T. Adenoviral-mediated delivery of the herpes simplex virus thymidine kinase gene selectively sensitizes human ovarian carcinoma cells to ganciclovir. Clin. Cancer Res., 1: 1571-1580, 1995.
18. Feng, M., Cabrera, G., Deshane, J., Scanlon, K., and Curiel, D. Neoplastic reversion accomplished by high efficiency adenoviral-mediated delivery of an anti-ras ribozyme. Cancer Res., 55: 2024-2028, 1995.
19. Lemarchand, P., Jaffe, H. A., Danel, C., Cid, M. C., Kleinman, H. K., Stratford-Perricaudet, L. D., Perricaudet, M., Pavirani, A., Lecocq, J. P., and Crystal, R. G. Adenovirus-mediated transfer of a recombinant human α1-antitrypsin cDNA to human endothelial cells. Proc. Natl. Acad. Sci. USA, 89: 6482-6486, 1992.
20. Caruso, M., Panis, Y., Gagandeep, S., Houssin, D., Salzmann, J-L., and Klatzman, D. Regression of established macroscopic liver metastases after transduction of a suicide gene. Proc. Natl. Acad. Sci. USA, 90: 7024-7028, 1993.
21. Freeman, S. M., Abboud, C. N., Whartenby, K. A., Packman, C. H., Kopelin, D. S., Moolten, F. L., and Abraham, G. N. The. "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res., 53: 5274-5283, 1993.
22. Ojeifo, J. O., Forough, R., Paik, S., Maciag, T., and Zwiebel, J. A. Angiogenesis-directed implantation of genetically modified endothelial cells in mice. Cancer Res., 55: 2240-2244, 1995.